Jeppson Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.54M Sell
18,256
-525
-3% -$73.5K 0.8% 30
2025
Q4
$2.31M Sell
18,781
-235
-1% -$28.6K 0.73% 35
2025
Q3
$2.11M Sell
19,016
-481
-2% -$54.7K 0.67% 35
2025
Q2
$2.16M Sell
19,497
-114
-0.6% -$12.1K 0.75% 33
2025
Q1
$2.2M Sell
19,611
-193
-1% -$19.9K 0.8% 29
2024
Q4
$1.83M Sell
19,804
-125
-0.6% -$11.3K 0.66% 34
2024
Q3
$1.67M Sell
19,929
-58
-0.3% -$4.43K 0.6% 43
2024
Q2
$1.37M Buy
19,987
+74
+0.4% +$4.94K 0.52% 51
2024
Q1
$1.46M Buy
19,913
+1,677
+9% +$129K 0.57% 49
2023
Q4
$1.48M Sell
18,236
-265
-1% -$20.6K 0.61% 43
2023
Q3
$1.39M Sell
18,501
-67
-0.4% -$5.15K 0.64% 38
2023
Q2
$1.43M Sell
18,568
-65
-0.3% -$5.18K 0.62% 39
2023
Q1
$1.55M Sell
18,633
-85
-0.5% -$7.04K 0.67% 34
2022
Q4
$1.61M Sell
18,718
-413
-2% -$32.7K 0.68% 31
2022
Q3
$1.18M Buy
19,131
+148
+0.8% +$9.33K 0.54% 42
2022
Q2
$1.17M Buy
18,983
+2,198
+13% +$136K 0.5% 45
2022
Q1
$997K Buy
16,785
+4,068
+32% +$260K 0.47% 54
2021
Q4
$923K Buy
12,717
+1,136
+10% +$78.2K 0.45% 56
2021
Q3
$808K Buy
11,581
+53
+0.5% +$3.72K 0.42% 59
2021
Q2
$793K Sell
11,528
-255
-2% -$17K 0.43% 59
2021
Q1
$761K Sell
11,783
-1,475
-11% -$95.1K 0.45% 53
2020
Q4
$772K Buy
13,258
+2,142
+19% +$129K 0.51% 51
2020
Q3
$702K Buy
+11,116
New +$771K 0.55% 50

Other funds holding GILD

Jeppson Wealth Management's GILD Position: Q1 2026 in Review

Jeppson Wealth Management reduced its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, selling an estimated $73.5K and leaving 18,256 shares worth $2.54M. The position accounts for 0.8% of the portfolio, ranked #30.

Jeppson Wealth Management first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jeppson Wealth Management held 18,256 shares of Gilead Sciences worth $2.54M as of Q1 2026.
  • Jeppson Wealth Management sold 525 Gilead Sciences shares in Q1 2026, an estimated $73.5K.
  • Gilead Sciences made up 0.8% of Jeppson Wealth Management's portfolio in Q1 2026, its #30 holding.
  • Jeppson Wealth Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jeppson Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.